Rakovina Therapeutics Inc Financial Flexibility Index
Rakovina Therapeutics Inc financial flexibility index. Rakovina Therapeutics Inc (RKV) has a Financial Flexibility Index of -0.31x as of September 2025. Free cash flow of CA$-1.04 Million (operating CF CA$-1.04 Million minus capex CA$0.00) represents 0% of total liabilities (CA$3.38 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Rakovina Therapeutics Inc (2021–2024)
Financial flexibility index of Rakovina Therapeutics Inc from 2021 to 2024. Historical Financial Flexibility Index trend for Rakovina Therapeutics Inc across 4 annual periods. Explore Rakovina Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Rakovina Therapeutics Inc Financial Flexibility Index by Year (2021–2024)
Rakovina Therapeutics Inc financial flexibility index by year from 2021 to 2024. Year-by-year free cash flow to debt coverage for Rakovina Therapeutics Inc. For the full cash flow conversion analysis, see Rakovina Therapeutics Inc (RKV) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.99x | CA$-3.86 Million | CA$-3.86 Million | CA$1.94 Million | ▼ -58.6% |
| 2023 | -1.25x | CA$-1.86 Million | CA$-1.86 Million | CA$1.49 Million | ▲ +93.0% |
| 2022 | -17.91x | CA$-1.92 Million | CA$-1.92 Million | CA$107.05K | ▲ +11.6% |
| 2021 | -20.25x | CA$-2.31 Million | CA$-2.31 Million | CA$113.98K | — |